NASDAQ$BTMD
biote Corp · Q1 2023 earnings
Q1 2023 earnings · · Investor relations
Briefing
Biote generated solid financial performance, driven by revenue growth and strategic initiatives in men's health.
Biote reported a 20.7% increase in revenue to $44.8 million for Q1 2023. The company launched a new initiative targeting the men's health market and maintained its 2023 financial guidance.
- Revenue increased by 20.7% year-over-year to $44.8 million.
- Gross profit margin improved by 220 basis points to 69.1%.
- Net loss was $(21.4) million, or $(0.39) per share, impacted by transaction-related items.
- Adjusted EBITDA increased by 12.4% to $13.1 million.
Headline financials
Revenue & EPS history
biote · Revenue · Quarterly
$44.8M
Forward guidance
Biote is maintaining its 2023 guidance, anticipating stronger revenue growth and Adjusted EBITDA performance in the second half of the year.
Tailwinds
- On track for continued growth in revenue and Adjusted EBITDA.
- Anticipates stronger revenue growth in the second half of the year.
- Expects stronger Adjusted EBITDA performance in the second half of the year.
- Will benefit from the contributions of sales personnel added at the end of 2022.
- Continues to invest to strengthen infrastructure and capabilities.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2023
-2.4%
Avg return
Earnings day
-4.0%
Avg return
5 days after
-3.0%
Avg return
30 days after
55%
11 / 20 earnings
Positive
+16.9%
Q3 2024
Best reaction
-25.1%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.9% | -9.6% | +4.6% | |
| Q4 2025 | -10.5% | -20.9% | -7.6% | |
| Q3 2025 | -2.4% | -11.1% | -13.0% | |
| Q1 2025 | +11.3% | +17.1% | +14.7% | |
| Q4 2024 | -25.1% | -0.7% | -11.0% | |
| Q3 2024 | +16.9% | -6.3% | +13.7% | |
| Q2 2024 | -21.2% | -17.8% | -10.6% | |
| Q1 2024 | +0.2% | +1.0% | +11.1% | |
| Q4 2023 | +11.9% | +27.0% | +10.1% | |
| Q3 2023 | -20.2% | -18.4% | -0.9% | |
| Q2 2023 | -14.4% | -22.0% | -23.7% | |
| Q1 2023 | -17.2% | -14.3% | -20.6% | |
| Q4 2022 | +16.6% | +34.9% | +33.3% | |
| Q3 2022 | +2.3% | +2.5% | +7.2% | |
| Q2 2022 | +1.1% | -4.6% | -7.4% | |
| Q1 2022 | +0.6% | -36.9% | -64.3% | |
| Q4 2021 | +0.0% | +0.0% | +0.6% | |
| Q3 2021 | -0.1% | +0.1% | +1.0% | |
| Q2 2021 | +0.0% | -0.5% | -0.2% | |
| Q1 2021 | +0.6% | +0.6% | +3.0% | |
| Q4 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro